Paclitaxel, carboplatin and 1,25-D3 inhibit proliferation of ovarian cancer cells in vitro

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs

Effects of aerobic and strength training on aerobic capacity, muscle strength, and gene expression of lymphomonocytes in patients with stable CAD

Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis

Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients

Altered polyamine profiles in colorectal cancer

Depletion of nuclear import protein karyopherin alpha 7 (KPNA7) induces mitotic defects and deformation of nuclei in cancer cells

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas

The Association Between Liver and Tumor [¹⁸F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy

The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes

A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production

European Code against Cancer 4th Edition

Medical exposures, including hormone therapy, and cancer

European Code against Cancer 4th Edition

Ionising and non-ionising radiation and cancer

European Code against Cancer 4th Edition

Ultraviolet radiation and cancer

Effects of single and fractionated irradiation on natural killer cell populations

Radiobiological characteristics of viability and cytotoxicity in vitro

Transcriptome sequencing reveals PCAT5 as a Novel ERG-Regulated long Noncoding RNA in prostate cancer

Reducing overdiagnosis by polygenic risk-stratified screening

Findings from the Finnish section of the ERSPC

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ngml^-1, normal DRE and negative for prostate cancer

Sotalol, but not digoxin is associated with decreased prostate cancer risk

A population-based case-control study

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

Human breast cancer cells educate macrophages toward the M2 activation status

Effects of remedies made in patient setup process on residual setup errors and margins in head and neck cancer radiotherapy based on 2D image guidance

MIR-25 modulates invasivenessand dissemination of human prostate cancer cells via regulation of αv-and α6-integrin expression

Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer

Long-term follow-up of the SPCG-6 study

Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer

The Finnish prostate cancer screening trial

Analyses on the screening failures

Family history in the finnish prostate cancer screening trial

Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies

Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway

European code against cancer 4th edition

12 ways to reduce your cancer risk

Early effects of adjuvant breast cancer radiotherapy on right ventricular systolic and diastolic function

The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer

VEGFR3 and CD31 as prognostic factors in renal cell cancer

Computational cancer biology

education is a natural key to many locks

Cost-effectiveness of prostate cancer screening

A simulation study based on ERSPC data

FRα

une cible pour la thérapie photodynamique prophylactique des métastases péritonéales ovariennes?

Estimation of optimal matching position for orthogonal kV setup images and minimal setup margins in radiotherapy of whole breast and lymph node areas

Claudins as prognostic factors for renal cell cancer

RE

Prostate-specific antigen screening trials and prostate cancer deaths: The androgen deprivation connection

Chernobyl fallout and cancer incidence in Finland 1988-2007

Impact of epoetin-beta on anemia and health-related quality of life in cancer patients

A prospective observational study using the generic 15D instrument

Hypermethylation of the GABRẼmiR-452̃miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy

Quality of life of recently treated patients with breast cancer

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression

A Novel MMP12 Locus Is Associated with Large Artery Atherosclerotic Stroke Using a Genome-Wide Age-at-Onset Informed Approach

Optimal management of metastatic castration-resistant prostate cancer

Highlights from a European Expert Consensus Panel

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

The diverse role of miR-31 in regulating cancer associated phenotypes

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

Bi-weekly paclitaxel and capecitabine as a second- Or third-line treatment for advanced breast cancer

A pilot study

Fallout from the Chernobyl accident and overall cancer incidence in Finland

Fine mapping of 11q13.5 identifies regions associated with prostate cancer and prostate cancer death

BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment

Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulation

Site-specific cancer risk in the Baltic cohort of Chernobyl cleanup workers, 1986-2007

Guggulsterone sensitizes glioblastoma cells to Sonic hedgehog inhibitor SANT-1 induced apoptosis in a Ras/NFκB dependent manner

Somatic mutation profiling and associations with prognosis and trastuzumab benefit in early breast cancer

Genetic markers associated with early cancer-specific mortality following prostatectomy

Weekly paclitaxel-An effective treatment for advanced breast cancer

Prostate cancer mortality in the finnish randomized screening trial

Obesity and physical inactivity are related to impaired physical health of breast cancer survivors

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis

Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level

Silencing of the arp2/3 complex disturbs pancreatic cancer cell migration

CIP2A expression and prognostic role in patients with esophageal adenocarcinoma

Multiple approaches and participation rate for a community based smoking cessation intervention trial in rural Kerala, India

Smoking cessation intervention in Rural Kerala, India

Findings of a randomised controlled trial

Cancer incidence among Nordic airline cabin crew

Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening

Sarcopenia during androgen-deprivation therapy for prostate cancer

Effectiveness of a 12-month exercise program on physical performance and quality of life of breast cancer survivors

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

Toxicity in patients receiving adjuvant docetaxel hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer

A preplanned safety report of the SPCG-13 trial

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer

Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo

No additional benefit of adding ifosfamide to docetaxel in castration-resistant metastatic prostate cancer

Novel Loci for Metabolic Networks and Multi-Tissue Expression Studies Reveal Genes for Atherosclerosis

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

Changes in circulating microRNA levels associated with prostate cancer

Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition

Adjuvant capecitabine, docetaxel, cyclophosphamide,and epirubicin for early breast cancer

Final analysis of the randomized FinXX trial

False-positive screening results in the European randomized study of screening for prostate cancer

Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy

The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH

4-year post hoc analysis of European men in the CombAT study

Genome-wide linkage scan for prostate cancer susceptibility in Finland

Evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22

Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab

The association between antihypertensive drug use and incidence of prostate cancer in Finland

A population-based case-control study

Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987-2007

NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene

Identification of an aggressive prostate cancer predisposing variant at 11q13

Thérapie photodynamique et carcinomes urothéliaux

Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression

Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability

An international prospective cohort study of mobile phone users and health (Cosmos)

Design considerations and enrolment

A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer